634 related articles for article (PubMed ID: 17596691)
21. Impact of APOE status on cognitive maintenance in healthy elderly persons.
Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R
Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
[TBL] [Abstract][Full Text] [Related]
22. Genetic variation in apolipoprotein E alters regional gray matter volumes in remitted late-onset depression.
Yuan Y; Zhang Z; Bai F; You J; Yu H; Shi Y; Liu W
J Affect Disord; 2010 Mar; 121(3):273-7. PubMed ID: 19647324
[TBL] [Abstract][Full Text] [Related]
23. APOE genotype modulates the effect of serum calcium levels on cognitive function in old age.
van Vliet P; Oleksik AM; Mooijaart SP; de Craen AJ; Westendorp RG
Neurology; 2009 Mar; 72(9):821-8. PubMed ID: 19255409
[TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C
Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C
Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066
[TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
[TBL] [Abstract][Full Text] [Related]
27. EEG functional connectivity and ApoE genotype in Alzheimer's disease and controls.
Kramer G; van der Flier WM; de Langen C; Blankenstein MA; Scheltens P; Stam CJ
Clin Neurophysiol; 2008 Dec; 119(12):2727-32. PubMed ID: 18848805
[TBL] [Abstract][Full Text] [Related]
28. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
Portaccio E; Goretti B; Zipoli V; Nacmias B; Stromillo ML; Bartolozzi ML; Siracusa G; Guidi L; Federico A; Sorbi S; De Stefano N; Amato MP
Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518
[TBL] [Abstract][Full Text] [Related]
29. The APOE-491 A/T promoter polymorphism effect on cognitive profile of Alzheimer's patients.
Valenza A; Bizzarro A; Marra C; Lauria A; Guglielmi V; Rossi C; Tiziano FD; Brahe C; Masullo C
Neurosci Lett; 2010 Mar; 472(3):199-203. PubMed ID: 20152880
[TBL] [Abstract][Full Text] [Related]
30. Distribution of APOE genotypes in a memory clinic cohort.
van der Flier WM; Pijnenburg YA; Schoonenboom SN; Dik MG; Blankenstein MA; Scheltens P
Dement Geriatr Cogn Disord; 2008; 25(5):433-8. PubMed ID: 18401171
[TBL] [Abstract][Full Text] [Related]
31. Relation of Apo E and ACE genes to cognitive performance in chronic alcoholic patients.
Bartrés-Faz D; Clemente IC; Monràs M; Muñoz M; López-Alomar A; Valveny N; Moral P; Gual A; Sánchez-Turet M; Guardia J; Junqué C
Addict Biol; 2002 Apr; 7(2):227-33. PubMed ID: 12006218
[TBL] [Abstract][Full Text] [Related]
32. Joint effect of hypertension and APOE genotype on CSF biomarkers for Alzheimer's disease.
Kester MI; van der Flier WM; Mandic G; Blankenstein MA; Scheltens P; Muller M
J Alzheimers Dis; 2010; 20(4):1083-90. PubMed ID: 20413898
[TBL] [Abstract][Full Text] [Related]
33. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.
Ewers M; Zhong Z; Bürger K; Wallin A; Blennow K; Teipel SJ; Shen Y; Hampel H
Brain; 2008 May; 131(Pt 5):1252-8. PubMed ID: 18334538
[TBL] [Abstract][Full Text] [Related]
34. Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease.
Nacmias B; Piccini C; Bagnoli S; Tedde A; Cellini E; Bracco L; Sorbi S
Neurosci Lett; 2004 Sep; 367(3):379-83. PubMed ID: 15337270
[TBL] [Abstract][Full Text] [Related]
35. Effect of ApoE genotype on response to donepezil in patients with Alzheimer's disease.
Choi SH; Kim SY; Na HR; Kim BK; Yang DW; Kwon JC; Park MY
Dement Geriatr Cogn Disord; 2008; 25(5):445-50. PubMed ID: 18401173
[TBL] [Abstract][Full Text] [Related]
36. Object naming and semantic fluency among individuals with genetic risk for Alzheimer's disease.
Miller KJ; Rogers SA; Siddarth P; Small GW
Int J Geriatr Psychiatry; 2005 Feb; 20(2):128-36. PubMed ID: 15660408
[TBL] [Abstract][Full Text] [Related]
37. Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia.
Pankratz N; Byder L; Halter C; Rudolph A; Shults CW; Conneally PM; Foroud T; Nichols WC
Mov Disord; 2006 Jan; 21(1):45-9. PubMed ID: 16116614
[TBL] [Abstract][Full Text] [Related]
38. ApoE alleles and tau markers in patients with different levels of cognitive impairment.
Lavados M; Farías G; Rothhammer F; Guillon M; Mujica MC; Maccioni C; Maccioni RB
Arch Med Res; 2005; 36(5):474-9. PubMed ID: 16099324
[TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults.
Pomara N; Willoughby L; Wesnes K; Greenblatt DJ; Sidtis JJ
Arch Gen Psychiatry; 2005 Feb; 62(2):209-16. PubMed ID: 15699298
[TBL] [Abstract][Full Text] [Related]
40. Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study.
Liu Y; Paajanen T; Westman E; Wahlund LO; Simmons A; Tunnard C; Sobow T; Proitsi P; Powell J; Mecocci P; Tsolaki M; Vellas B; Muehlboeck S; Evans A; Spenger C; Lovestone S; Soininen H;
J Alzheimers Dis; 2010; 21(3):947-66. PubMed ID: 20693633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]